Пищеварительная система при антипсихотической терапии (обзор литературы). Часть IV: ятрогенная патология печени (эффект типичных антипсихотиков)
Аннотация
Антипсихотические препараты, широко использующиеся в медицинской практике, обладают обширным спектром негативных побочных эффектов, в том числе действующих на органы системы пищеварения. В четвертой части предлагаемого обзора рассмотрена патология печени, ассоциированная с приемом отдельных конкретных антипсихотических препаратов первого поколения.
Список литературы
1. Akesson H. O. [3 cases of jaundice related to Nozinan treatment] // Sven. Lakartidn.- 1960.- Vol. 57.- 3607-3608.
2. Alcalâ-Santaella R., Pacheco A. F., Robles J. [Apropos of primary biliary cirrhosis induced by chlorpromazine and its therapy with cholestyramine] // Rev. Clin. Esp.- 1968.- Vol. 108, N5.- P. 366-372.
3. Antipsychotic Agents. [Электронный ресурс].- URL: http://livertox.nih.gov/AntipsychoticAgents.htm (дата обращения: 15.10.2016).
4. Ayd F. J. Jr. Chlorpromazine: ten years' experience // JAMA.- 1963.- Vol. 184.- P. 51-54.
5. Barancik M., Brandborg L. L., Albion M. J. Thioridazine-induced cholestasis // JAMA.- 1967.- Vol. 200, N 1.- P. 69-70.
6. Bartholomew L. G., Cain J. C. Chlorpromazine hepatitis without clinical jaundice // Proc. Staff. Meet. Mayo Clin.- 1956.- Vol. 31, N7.- P. 201-204.
7. Beattie A. S., Farris J. M., Frempter G. R. Hepatohypercholesterolemic cirrhosis: report of a case implicating chlorpromazine as the etiologic agent// Calif. Med.- 1959.- Vol. 91.- P. 154-155.
8. Bhatia S. C., Banta L.E., Ehrlich D. W. Molindone andhepatotoxicity //DrugIntell. Clin. Pharm.- 1985.- Vol. 19, N 10.- P. 744-746.
9. Block S.L. Jaundice following thioridazine administration // Am. J. Psychiatry.- 1962.- Vol. 119.- P. 77. doi: 10.1176/ajp.119.1.77
10. Boardman R. H. Fatal case of toxic hepatitis implicating chlorpromazine.- Br. Med. J.- 1954.- Vol. 2, N4887.- P. 579.
11. Bolton B. H. Prolonged chlorpromazine jaundice // Am.J. Gastroenterol.- 1967.- Vol. 48, N6.- P. 497-503.
12. Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study / J. P. Molleston, R. J. Fontana, M.J. Lopez [et al.] // J. Pediatr. Gastroenterol. Nutr.- 2011.- Vol. 53, N2.- P. 182-189.
13. Chlorpromazine. [Электронный ресурс].- URL: livertox.nih.gov/Chlorpromazine.htm (дата обращения: 15.10.2016).
14. Chlorpromazine-induced cholestatic liver disease with ductopenia / A. Chlumskâ, R. Curik, L. Boudovâ [etal.] // Cesk. Patol. - 2001. - Vol. 37, N3.- P. 118-122.
15. Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis / D. Moradpour, J. Altorfer, R. Flury [et al.] // Hepatology.- 1994.- Vol. 20, N6.- P. 1437-1441.
16. [Cholestatic hepatitis in a patient taking levomepromazine] / H. Pierson, M. A. Preiss, F. Penin [et al.] // Ann. Gastroenterol. Hepatol. (Paris).- 1987.- Vol. 23, N2.- P. 101.
17. Cook GC, Sherlock S. Jaundice and its relation to therapeutic agents // Lancet.- 1965.- Vol. 1, N7378.- P. 175-179.
18. Crane G. E. A review of clinical literature on haloperidol// Int. J. Neuropsychiatry.- 1967. - Vol. 3, Suppl 1.- P. 110-127.
19. Crause J. Jaundice associated with haloperidol // Lancet.- 1963.- Vol. 2, N 7313.- P. 890-891.
20. [Cytolytic hepatitis during treatment with phenothiazines: apropos of a case] / G. Mesure, F. Bayle, J.M. Vanelle [et al.] // Encephale.- 1996.- Vol. 22, N5.- P. 388-390.
21. DePaulo J. R. Jr., Ayd F.J. Jr. Loxapine: fifteen years' clinical experience // Psychosomatics. - 1982.- Vol. 23, N3.- P. 261-271.
22. Dincsoy H. P., Saelinger D. A. Haloperidol-induced chronic cholestatic liver disease // Gastroenterology.- 1982.- Vol. 83, N3.- P. 694-700.
23. Double-blind maintenance safety and effectiveness findings from the treatment of early-onsetschizophrenia spectrum (TEOSS) study / R. L. Findling, J. L. Johnson, J. McClellan [et al.] // J. Am. Acad. Child. Adolesc. Psychiatry.- 2010.- Vol. 49, N6.- P. 583-594.
24. Effect of chlorpromazine on isolated rat hepatocytes / S. C. Tsao, T. Iga, Y. Sugiyama [et al.] // Biochem. Pharmacol.- 1982.- Vol. 31, N4.- P. 491-497.
25. Fluphenazine. [Электронный ресурс].- URL: http://livertox.nih.gov/Fluphenazine.htm (дата обращения: 15.10.2016).
26. Fuller C. H. A death due to chlorpromazine hepatitis // BMQ.- 1959.- Vol. 10, N 1.- P. 13-16.
27. Gerle B. Clinical observations of the side effects of haloperidol// Acta Psychiatr. Scand.- 1964.- Vol. 40. - P. 65-76.
28. Grytting G. [Toxic liver damage due to largactil (chlorpromazine)] // Nord. Med.- 1954. - Vol. 52, N49.- P. 1699-1701.
29. Gupta N.N., Pant S. S., Mehrotra R.M. Toxic effects of chlorpromazine with special reference to jaundice // Indian. J. Med. Sci.- 1962. - Vol. 16.- P. 315-323.
30. Haloperidol. [Электронный ресурс].- URL: http://livertox.nih.gov/Haloperidol.htm (дата обращения: 15.10.2016).
31. Haloperidol-induced liver disease / C.M. Fuller, S. Yassinger, P. Donlon [et al.] // West J. Med.- 1977.- Vol. 127, N6.- P. 515-518.
32. Hansen T. E., Casey D. E., Hoffman W.F. Neuroleptic intolerance // Schizophr. Bull.- 1997.- Vol. 23, N4.- P. 567-582.
33. Hargreaves T. Cholestatic drugs and bilirubin metabolism // Nature.- 1965.- Vol. 206, N 980.- P. 154-156.
34. Hartnett B. S. Liver damage and eosinophilia following chlorpromazine therapy; report of a case // Br. Med. J.- 1955.-Vol. I, N4928.-P. 1458-1459.
35. [Hepatic tolerance of atypical antipsychotic drugs] / G. Dumortier, W. Cabaret, L. Stamatiadis [et al.] // Encephale.- 2002.- Vol. 28, N 6, Pt 1.- P. 542-551.
36. Hepatotoxicity of clozapine / M. Hummer, M. Kurz, I. Kurzthaler [et al.] // J. Clin. Psychopharmacol.- 1997. - Vol. 17, N4. - P. 314-317.
37. Herron G., Bourdo S. Jaundice secondary to promazine, and an analysis of possible cross sensitivities between phenothiazine derivatives // Gastroenterology.- 1960.- Vol. 38.- P. 87-90.
38. Hollister L. E. Allergy to chlorpromazine manifested by jaundice // Am. J. Med.- 1957. - Vol. 23, N6.- P. 870-879.
39. Holt RJ. Fluphenazine decanoate-induced cholestatic jaundice and thrombocytopenia // Pharmacotherapy.- 1984.- Vol. 4, N4.- P. 227-229.
40. Hurt P., Wegmann T. [Protracted Largactil jaundice developing into primary biliary cirrhosis] // Acta Hepatosplenol.- 1961.- Vol. 8. - P. 87-95.
41. Ishak K. G., Irey N. S. Hepatic injury associated with thephenothiazines. Clinicopathologic and follow-up study of 36 patients // Arch. Pathol.- 1972.- Vol. 93, N4.- P. 283-304.
42. Jacobson J. R., Turkel S. B. Elevated liver enzymes associated with fluphenazine used to manage delirium symptoms in infants // J. Child. Adolesc. Psychopharmacol.- 2013. - Vol. 23, N7. - P. 513-514. doi: 10.1089/ cap.2013.0047
43. Kane F. J. Jr., Moore L. P. Hepatotoxicity occurring with thioridazine therapy // South Med. J.- 1971.- Vol. 64, N5.- P. 573.
44. Kemp J. A. Jaundice occurring during administration of promazine // Gastroenterology.- 1957.- Vol. 32, N5.- P. 937-938.
45. Kohn N., Myerson R. M. Cholestatic hepatitis associated with trifluoperazine // N. Engl. J. Med.- 1961.- Vol. 264.- P. 549-550. doi: 10.1056/NEJM196103162641107
46. Kohn N., Myerson R.M. Xanthomatous biliary cirrhosis following chlorpromazine // Am. J. Med.- 1961. - Vol. 31, N4. - P. 665-670. doi: 10.1016/0002-9343(61)90150-4
47. Kristensen O. [Icterus induced by thioridazine (Melleril). Report of 1 case] // Tidsskr. Nor. Laegeforen.- 1975. - Vol. 95, N33. - P. 1910-1911.
48. Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver // Semin. Liver Dis. - 2002. - Vol. 22, N 2.- P. 145-155. doi: 10.1055/s-2002-30105
49. Larry D., Ripault M. P. Hepatotoxicity of psychotropic drugs and drugs of abuse // Drug-induced liver disease / N. Kaplowitz, L. D. DeLeve (eds.). - 3rd ed. - Amsterdam: Elsevier, 2013.- P. 447-462.
50. Leipzig R. M. Gastrointestinal and hepatic effects of psychotropic drugs // Adverse Effects of Psychotropic Drugs / J. A. Lieberman, J. M. Kane (eds.).-NY: Guilford Press, 1992.- P. 408-430.
51. Lok A. S., Ng I. O. Prochlorperazine-induced chronic cholestasis // J. Hepatol.- 1988.- Vol. 6, Is 3.- P. 369-373. doi: 10.1016/S 0168-8278(88)80056-4
52. Long-term study of molindone hydrochloride in chronic schizophrenics / R. Kellner, R. T. Rada, A. Egelman [etal.] // Curr. Ther. Res. Clin. Exp.- 1976.- Vol. 20, N 5.- P. 686-694.
53. Loxapine. [Электронный ресурс].- URL: h ttp://www. livertox. n ih.gov/Loxapin e. htm (дата обращения: 15.10.2016).
54. Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent/ R. C. Heel, R. N. Brogden, T. M. Speight [et al.] // Drugs.- 1978.- Vol. 15, N 3.- P. 198-217.
55. Margulies A. I., Berris B. Jaundice associated with the administration of trifluoperazine // Can. Med. Assoc. J.- 1968.- Vol. 98, N. 22.- P. 1063-1064.
56. Marivick K. F., Taylor M., Walker S. W. Antipsychotics and abnormal liver function tests: systematic review // Clin. Neuropharmacol.- 2012.- Vol. 35, N5.- P. 244-253. doi: 10.1097/ WNF.0b013e31826818b6
57. McQueen E.G. Toxic effects of phenothiazine tranquillizers // N. 2. Med. J.- 1963. - Vol. 62.- P. 460-462.
58. Mechanic R. C., Meyers L. Chlorpromazine-type cholangitis; report of a case occurring after the administration of prochlorperazine // N. Engl. J. Med.- 1958.- Vol. 259, N 16.- P. 778-780. doi: 10.1056/NEJM195810162591607
59. Melrose A. G., Roy J. R. Late prognosis of chlorpromazine jaundice // Br. Med. J.- 1959. - Vol. 1, N5125.- P. 818-819.
60. Molecular cytotoxic mechanisms of chlorpromazine in isolated rat hepatocytes / S. L. MacAllister, C. Young, A. Guzdek [etal.] // Can. J. Physi ol. Pharmacol.- 2013. - Vol. 91, N 1.- P. 56-63. doi: 10.1139/cjpp-2012-0223
61. Molindone. [Электронный ресурс].- URL: http://www.livertox.nih.gov/Molindone.htm (дата обращения: 15.10.2016).
62. Morera Prat J., Vidal Pla R., Mari M. L. [Primary biliary cirrhosis after a prolonged ingestion of chlorpromazine] // Rev. Clin. Esp.- 1976. - Vol. 142, N5.- P. 483-485.
63. Munyon W. H., Salo R., Briones D. F. Cytotoxic effects of neuroleptic drugs // Psychopharmacology (Berl.).- 1987.- Vol. 91, N2.- P. 182-188.
64. Norris T. S. Promethazine and drug-induced jaundice // Lancet.- 1963.- Vol. 1, N7277.- P. 394.
65. Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells / S. Anthérieu, P. Bachour-El Azzi, J. Dumont [et al.] // Hepatology.- 2013.- Vol. 57, N4.- P. 1518-1529. doi: 10.1002/hep.26160
66. Pantel J., Schröder J. Acute hepatitis, rhabdomyolisis and pancytopenia associated with perazine therapy // Pharmacopsychiatry.- 1996.- Vol. 29, N 1. - P. 43. doi: 10.1055/s-2007-979543
67. Patterson J. F. Amoxapine associated with hepatotoxicity // J. Clin. Psychopharmacol.- 1987.- Vol. 7, N 1.- P. 50-51.
68. Perphenazine. [Электронный ресурс]. - URL: http://livertox.nih.gov/Perphenazine.htm (дата обращения: 15.10.2016).
69. Pillans P. I. Drug associated hepatic reactions in New Zealand: 21 years experience // N.Z. Med. J.- 1996.- Vol. 109, N 1028.- P. 315-319.
70. Prochlorperazine. [Электронный ресурс].- URL: http://livertox.nih.gov/Prochlorperazine. htm (дата обращения: 15.10.2016).
71. Prochlorperazine-induced cholestasis in a patient with alpha-1 antitrypsin deficiency / A. L. Mindikoglu, A. Anantharaju, G. G. Hartman [et al.] // Hepatogastroenterology.- 2003.- Vol. 50, N53.- P. 1338-1340.
72. Ranek L. [A fatal case of prolonged chlorpromazine jaundice] // Ugeskr. Laeger.- 1964. - Vol. 126.- P. 1271-1274.
73. Read A. E., Harrison C. V., Sherlovk S. Chronic chlorpromazine jaundice: with particular reference to its relationship to primary biliary cirrhosis // Am. J. Med.- 1961.- Vol. 31. - P. 249-258.
74. Regal R.E., Bili J.E., Glazer H. M. Phenothiazine-induced cholestatic jaundice // Clin. Pharm.- 1987.- Vol. 6, N 10.- P. 787-794.
75. Relevance of liver enzyme elevations with four different neuroleptics: a retrospective review of 7,263 treatment courses /I. Gaertner, K. Altendorf, A. Batra [et al.] // J. Clin. Psychopharmacol.- 2001. - Vol. 21, N2. - P. 215-222.
76. Risk of acute liver injury associated with the use of drugs: a multicentre population survey / M. Sabaté, L. Ibánez, E. Pérez [et al.] // Aliment. Pharmacol. Ther. - 2007.- Vol. 25, N 12.- P. 1401-1409. doi: 10.1111/j.1365-2036.2007.03338.x
77. Rodin A. E., Robertson D.M. Fatal toxic hepatitis following chlorpromazine therapy; report of a case with autopsy findings // AMA Arch. Pathol.- 1958.- Vol. 66, N2.- P. 170-175.
78. Sex-dependent metabolic alterations of rat liver after 12-week exposition to haloperidol or clozapine / M. von Wilmsdorff, M. L. Bouvi er, U. Henning [et al.] // Horm. Metab. Res.- 2014. - Vol. 46, N 11. - P. 782-788. doi: 10.1055/ s-0034-1384605
79. Snyder S. Fluphenazine jaundice. Report of a case // Am.J. Gastroenterol.- 1980.- 73, N4.- P. 336-340.
80. Solomon F. A. Jr., Campagna F. A. Jaundice due to prochlorperazine (compazine) // Am. J. Med.- 1959.- Vol. 27.- P. 840-843.
81. Spirtes M.A., Guth P.S. Effects of chlorpromazine on biological membranes-I. Chlorpromazine-induced changes in liver mitochondria // Biochem. Pharmacol.- 1963.- Vol. 12.- P. 37-46.
82. Stine J. G., Chalasani N. Chronic liver injury induced by drugs: a systematic review // Liver Int. - 2015. - Vol. 35, N 11.- P. 2343-2353. doi: 10.1111/liv.12958
83. Suggestive evidence of hepatotoxicity concomitant with thioridazine hydrochloride use / M.J. Reinhart, R.M. Benson, S. K. Kwass[etal.] // JAMA.- 1966.- Vol. 197, N 10.- P. 767-769.
84. The effect of chlorpromazine, promethazine, and diphenhydramine on swelling of isolated liver mitochondria / E. E. Smith, C. Watanabe, J. Louie [et al.] // Biochem. Pharmacol.- 1964.- Vol. 13.- P. 643-657.
85. Thioridazine. [Электронный ресурс].- URL: http://livertox.nih.gov/Thioridazine.htm (дата обращения: 15.10.2016).
86. Trifluoperazine. [Электронный ресурс].- URL: http://livertox.nih.gov/Trifiuoperazine.htm (дата обращения: 15.10.2016).
87. Trifiuoperazine-induced cholestatic jaundice / V. Sharifi, S. Amini, P. Ghaeli[etal.] // Iran J. Psychiatry.- 2010 - Vol. 5, N3.- P. 117-118.
88. Urberg M. Thioridazine-induced non-icteric hepatotoxicity. Report of a case // J. Fam. Pract.- 1990.- Vol. 30, N3.- P. 342-343.
89. Walker C. O., Combes B. Biliary cirrhosis induced by chlorpromazine // Gastroenterology.- 1966.- Vol. 51, N5.- P. 631-640.
90. Walters G.M., Terrence C., Steckel R. Jaundice following administration of fluphenazine dihydrochloride // Am. J, Psychiatry.- 1963.- Vol. 120.- P. 81-82. doi:10.1176/ajp.120.1.81
91. Weiden P. L., Buckner C. D. Thioridazine toxicity. Agranulocytosis and hepatitis with encephalopathy // JAMA.- 1973.- Vol. 224, N4.- P. 518-520.
92. Wen B., Zhou M. Metabolic activation of the phenothiazine antipsychotics chlorpromazine and thioridazine to electrophilic iminoquinone species in human liver microsomes and recombinant P450s // Chem. Biol. Interact.- 2009. - Vol. 181, N 2. - P. 220-226. doi: 10.1016/j. cbi.2009.05.014
93. Werther J. L., Korelitz B. I. Chlorpromazine jaundice; analysis of twenty-two cases.- Am.J. Med.- 1957.- Vol. 22, N3.- P. 351-366.
94. Xanthomatous biliary cirrhosis following chlorpromazine, with observations indicating overproduction of cholesterol, hyperprothrombin-emia, and the development of portal hypertension / J. D. Myers, R. E. Olson, J. H. Lewis [et al.] // Trans. Assoc. Am. Physicians.- 1957.- Vol. 70. - P. 243-261.
95. Zatuchni J., Miller G. Jaundice during chlorpromazine therapy // N. Engl. J. Med.- 1954.- Vol. 251, N25.- P. 1003-1006. doi: 10.1056/ NEJM195412162512503
96. Zelman S. Liver cell necrosis in chlorpromazine jaundice (allergic cholangiolitis). A serial study of twenty-six needle biopsy specimens in nine patients // Am.J. Med.- 1959.- Vol. 27.- P. 708-729.
97. Zimmerman H. J. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. - 2nd ed.- Philadelphia: Lippincott Williams a. Wilkins, 1999.- 789 p.
Рецензия
Для цитирования:
Волков В.П. Пищеварительная система при антипсихотической терапии (обзор литературы). Часть IV: ятрогенная патология печени (эффект типичных антипсихотиков). Медицинский алфавит. 2017;2(19):39-42.
For citation:
Volkov V.P. System of digestion under antipsychotic therapy (literature review). Part IV: iatrogenic pathology of liver (effect of typical antipsychotics). Medical alphabet. 2017;2(19):39-42. (In Russ.)
Просмотров:
202
Послать статью по эл. почте 